Sonic Hedgehog signaling pathway in gynecological and genitourinary cancer (Review)
- Authors:
- Anna Kotulak‑Chrząszcz
- Zbigniew Kmieć
- Piotr M. Wierzbicki
-
Affiliations: Department of Histology, Faculty of Medicine, Medical University of Gdansk, 80211 Gdansk, Poland - Published online on: April 16, 2021 https://doi.org/10.3892/ijmm.2021.4939
- Article Number: 106
-
Copyright: © Kotulak‑Chrząszcz et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Bellmunt J, Orsola A, Leow JJ, Wiegel T, De Santis M and Horwich A: Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 25:iii40–iii48. 2014. View Article : Google Scholar : PubMed/NCBI | |
Parker C, Gillessen S, Heidenreich A and Horwich A: Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 26:v69–v77. 2015. View Article : Google Scholar : PubMed/NCBI | |
Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A and Colombo N: Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 28(suppl-4): iv72–iv83. 2017. View Article : Google Scholar : PubMed/NCBI | |
Colombo N, Preti E, Landoni F, Carinelli S, Colombo A and Marini C; ESMO Guidelines Working Group: Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 24(Suppl 6): vi33–vi38. 2013. View Article : Google Scholar : PubMed/NCBI | |
Ray-Coquard I, Morice P, Lorusso D, Prat J, Oaknin A, Pautier P and Colombo N; ESMO Guidelines Committee: Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 29(Suppl 4): iv1–iv18. 2018. View Article : Google Scholar : PubMed/NCBI | |
Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, Grünwald V, Gillessen S, Horwich A, et al ESMO Guidelines Committee: Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 30:706–720. 2019. View Article : Google Scholar : PubMed/NCBI | |
Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, Morice P, Pignata S, Ray-Coquard I, Vergote I, et al: ESMO-ESGO consensus conference recommendations on ovarian cancer: Pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol. 30:672–705. 2019. View Article : Google Scholar : PubMed/NCBI | |
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, Znaor A and Bray F: Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 144:1941–1953. 2019. View Article : Google Scholar | |
Bankhead CR, Kehoe ST and Austoker J: Symptoms associated with diagnosis of ovarian cancer: A systematic review. BJOG. 112:857–865. 2005. View Article : Google Scholar : PubMed/NCBI | |
Hsieh JJ, Purdue MP, Signoretti S, Swanton C, Albiges L, Schmidinger M, Heng DY, Larkin J and Ficarra V: Renal cell carcinoma. Nat Rev Dis Primers. 3:170092017. View Article : Google Scholar : PubMed/NCBI | |
Nüsslein-Volhard C and Wieschaus E: Mutations affecting segment number and polarity in Drosophila. Nature. 287:795–801. 1980. View Article : Google Scholar : PubMed/NCBI | |
Rivell A, Petralia RS, Wang YX, Clawson E, Moehl K, Mattson MP and Yao PJ: Sonic hedgehog expression in the postnatal brain. Biology Open. 8:bio0405922019. View Article : Google Scholar : PubMed/NCBI | |
Fattahi S, Pilehchian Langroudi M and Akhavan-Niaki H: Hedgehog signaling pathway: Epigenetic regulation and role in disease and cancer development. J Cell Physiol. 233:5726–5735. 2018. View Article : Google Scholar : PubMed/NCBI | |
Wang C, Cassandras M and Peng T: The Role of hedgehog signaling in adult lung regeneration and maintenance. J Dev Biol. 7:142019. View Article : Google Scholar : | |
Skoda AM, Simovic D, Karin V, Kardum V, Vranic S and Serman L: The role of the Hedgehog signaling pathway in cancer: A comprehensive review. Bosn J of Basic Med Sci. 18:8–20. 2018. View Article : Google Scholar | |
Cohen M, Kicheva A, Ribeiro A, Blassberg R, Page KM, Barnes CP and Briscoe J: Ptch1 and Gli regulate Shh signalling dynamics via multiple mechanisms. Nat Commun. 6:67092015. View Article : Google Scholar : PubMed/NCBI | |
Katoh M: Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers. Clin Sci. 133:953–970. 2019. View Article : Google Scholar | |
Girardi D, Barrichello A, Fernandes G and Pereira A: Targeting the hedgehog pathway in cancer: Current evidence and future perspectives. Cells. 8:1532019. View Article : Google Scholar : | |
Hua K and Ferland RJ: Primary cilia proteins: Ciliary and extraciliary sites and functions. Cell Mol Life Sci. 75:1521–1540. 2018. View Article : Google Scholar : PubMed/NCBI | |
Carballo GB, Honorato JR, de Lopes GPF and Spohr TCL DESE: A highlight on Sonic hedgehog pathway. Cell Commun Signal. 16:112018. View Article : Google Scholar : PubMed/NCBI | |
Didiasova M, Schaefer L and Wygrecka M: Targeting GLI transcription factors in cancer. Molecules. 23:10032018. View Article : Google Scholar : | |
ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knüchel R and Dahl E: Expression of the glioma-associated oncogene homolog (GLI) 1in human breast cancer is associated with unfavourable overall survival. BMC Cancer. 9:2982009. View Article : Google Scholar | |
Im S, Choi HJ, Yoo C, Jung JH, Jeon YW, Suh YJ and Kang CS: Hedgehog related protein expression in breast cancer: Gli-2 is associated with poor overall survival. Korean J Pathol. 47:116–123. 2013. View Article : Google Scholar : PubMed/NCBI | |
Choe JY, Yun JY, Jeon YK, Kim SH, Choung HK, Oh S, Park M and Kim JE: Sonic hedgehog signalling proteins are frequently expressed in retinoblastoma and are associated with aggressive clinicopathological features. J Clin Pathol. 68:6–11. 2015. View Article : Google Scholar | |
Al Ghamdi D, Gomaa W, Abulaban A, Al-Ahwal M, Buhmeida A, Al-Qahtani M and Al-Maghrabi J: The significance of sonic hedgehog immunohistochemical expression in colorectal carcinoma. J Microsc Ultrastruct. 3:169–174. 2015. View Article : Google Scholar : PubMed/NCBI | |
Bai XY, Lin JY, Zhang XC, Xie Z, Yan HH, Chen ZH, Xu CR, An SJ, Sheng GM and Wu YL: High expression of truncated GLI3 is associated with poor overall survival in patients with non-small cell lung cancer. Cancer Biomark. 13:37–47. 2013. View Article : Google Scholar : PubMed/NCBI | |
Ding YL, Wang QS, Zhao WM and Xiang L: Expression of smoothened protein in colon cancer and its prognostic value for postoperative liver metastasis. Asian Pac J Cancer Prev. 13:4001–4005. 2012. View Article : Google Scholar : PubMed/NCBI | |
Aberger F and Frischauf AM: GLI Genes and Their Targets in Epidermal Development and Disease. Landes Bioscience. 2013. | |
Lesiak A, Sobolewska-Sztychny D, Danilewicz M, Rogowski-Tylman M, Sysa-Jedrzejowska A, Sobjanek M, Olejniczak-Staruch I and Narbutt J: Sonic hedgehog pathway dysregulation in skin basal-cell carcinoma of a Polish population. Folia Histochem Cytobiol. 51:219–224. 2013. View Article : Google Scholar : PubMed/NCBI | |
Liu F, Jiang W, Sui Y, Meng W, Hou L, Li T, Li M, Zhang L, Mo J, Wang J, et al: CDK7 inhibition suppresses aberrant hedgehog pathway and overcomes resistance to smoothened antagonists. Proc Natl Acad Sci USA. 116:12986–12995. 2019. View Article : Google Scholar : PubMed/NCBI | |
Fernandes-Silva H, Correia-Pinto J and Moura RS: Canonical sonic hedgehog signaling in early lung development. J Dev Biol. 5:32017. View Article : Google Scholar | |
Memi F, Zecevic N and Radonjić N: Multiple roles of Sonic Hedgehog in the developing human cortex are suggested by its widespread distribution. Brain Struct Funct. 223:2361–2375. 2018. View Article : Google Scholar : PubMed/NCBI | |
Odent S, Attie-Bitach T, Blayau M, Mathieu M, Aug J, Delezo de AL, Gall JY, Le Marec B, Munnich A, David V and Vekemans M: Expression of the Sonic hedgehog (SHH) gene during early human development and phenotypic expression of new mutations causing holoprosencephaly. Hum Mol Genet. 8:1683–1689. 1999. View Article : Google Scholar : PubMed/NCBI | |
Kim A, Le Douce J, Diab F, Ferovova M, Dubourg C, Odent S, Dupé V, David V, Diambra L, Watrin E and de Tayrac M: Synonymous variants in holoprosencephaly alter codon usage and impact the Sonic Hedgehog protein. Brain. 143:2027–2038. 2020. View Article : Google Scholar : PubMed/NCBI | |
Fabik J, Kovacova K, Kozmik Z and Machon O: Neural crest cells require Meis2 for patterning the mandibular arch via the Sonic hedgehog pathway. Biol Open. 9:bio0520432020. View Article : Google Scholar : PubMed/NCBI | |
Bürglin TR: The Hedgehog protein family. Genome Biol. 9:2412008. View Article : Google Scholar : PubMed/NCBI | |
Hanna A and Shevde LA: Hedgehog signaling: Modulation of cancer properies and tumor mircroenvironment. Mol Cancer. 15:242016. View Article : Google Scholar : PubMed/NCBI | |
Nikolopoulou E, Galea GL, Rolo A, Greene NDE and Copp AJ: Neural tube closure: Cellular, molecular and biomechanical mechanisms. Development. 144:552–566. 2017. View Article : Google Scholar : PubMed/NCBI | |
Roessler E, Belloni E, Gaudenz K, Vargas F, Scherer SW, Tsui LC and Muenke M: Mutations in the C-terminal domain of sonic hedgehog cause holoprosencephaly. Hum Mol Genet. 6:1847–1853. 1997. View Article : Google Scholar : PubMed/NCBI | |
Mimeault M and Batra SK: Frequent deregulations in the hedgehog signaling network and cross-talks with the epidermal growth factor receptor pathway involved in cancer progression and targeted therapies. Pharmacol Rev. 62:497–524. 2010. View Article : Google Scholar : PubMed/NCBI | |
Varjosalo M and Taipale J: Hedgehog: Functions and mechanisms. Genes Dev. 22:2454–2472. 2008. View Article : Google Scholar : PubMed/NCBI | |
Chamoun Z, Mann RK, Nellen D, von Kessler DP, Bellotto M, Beachy PA and Basler K: Skinny hedgehog, an acyltransferase required for palmitoylation and activity of the hedgehog signal. Science. 293:2080–2084. 2001. View Article : Google Scholar : PubMed/NCBI | |
Lanyon-Hogg T, Masumoto N, Bodakh G, Konitsiotis AD, Thinon E, Rodgers UR, Owens RJ, Magee AI and Tate EW: Synthesis and characterisation of 5-acyl-6,7-dihydrothieno[3,2-c] pyridine inhibitors of Hedgehog acyltransferase. Data Brief. 7:257–281. 2016. View Article : Google Scholar : PubMed/NCBI | |
Rodgers UR, Lanyon-Hogg T, Masumoto N, Ritzefeld M, Burke R, Blagg J, Magee AI and Tate EW: Characterization of hedgehog acyltransferase inhibitors identifies a small molecule probe for hedgehog signaling by cancer cells. ACS Chem Biol. 11:3256–3262. 2016. View Article : Google Scholar : PubMed/NCBI | |
Gong X, Qian H, Cao P, Zhao X, Zhou Q, Lei J and Yan N: Structural basis for the recognition of Sonic Hedgehog by human Patched1. Science. 361:eaas89352018. View Article : Google Scholar : PubMed/NCBI | |
Choudhry Z, Rikani AA, Choudhry AM, Tariq S, Zakaria F, Asghar MW, Sarfraz MK, Haider K, Shafiq AA and Mobassarah NJ: Sonic hedgehog signalling pathway: A complex network. Ann Neurosci. 21:28–31. 2014. View Article : Google Scholar : PubMed/NCBI | |
Bausch D, Fritz S, Bolm L, Wellner UF, Fernandez-Del-Castillo C, Warshaw AL, Thayer SP and Liss AS: Hedgehog signaling promotes angiogenesis directly and indirectly in pancreatic cancer. Angiogenesis. 23:479–492. 2020. View Article : Google Scholar : PubMed/NCBI | |
Qi X, Schmiege P, Coutavas E, Wang J and Li X: Structures of human Patched and its complex with native palmitoylated sonic hedgehog. Nature. 560:128–132. 2018. View Article : Google Scholar : PubMed/NCBI | |
Martinez MF, Romano MV, Martinez AP, González A, Muchnik C, Stengel FM, Mazzuoccolo LD and Azurmendi PJ: Nevoid Basal Cell Carcinoma Syndrome: PTCH1 mutation profile and expression of genes involved in the hedgehog pathway in argentinian patients. Cells. 8:1442019. View Article : Google Scholar : | |
Fleet AJ and Hamel PA: The protein-specific activities of the transmembrane modules of Ptch1 and Ptch2 are determined by their adjacent protein domains. J Biol Chem. 293:16583–16595. 2018. View Article : Google Scholar : PubMed/NCBI | |
Holtz AM, Peterson KA, Nishi Y, Morin S, Song JY, Charron F, McMahon AP and Allen BL: Essential role for ligand-dependent feedback antagonism of vertebrate hedgehog signaling by PTCH1, PTCH2 and HHIP1 during neural patterning. Development. 140:3423–3434. 2013. View Article : Google Scholar : PubMed/NCBI | |
Kowatsch C, Woolley RE, Kinnebrew M, Rohatgi R and Siebold C: Structures of vertebrate Patched and Smoothened reveal intimate links between cholesterol and Hedgehog signalling. Curr Opin Struct Biol. 57:204–214. 2019. View Article : Google Scholar : PubMed/NCBI | |
Xiao X, Tang JJ, Peng C, Wang Y, Fu L, Qiu ZP, Xiong Y, Yang LF, Cui HW, He XL, et al: Cholesterol modification of smoothened is required for hedgehog signaling. Mol Cell. 66:154–162.e10. 2017. View Article : Google Scholar : PubMed/NCBI | |
Denef N, Neubüser D, Perez L and Cohen SM: Hedgehog induces opposite changes in turnover and subcellular localization of patched and smoothened. Cell. 102:521–531. 2000. View Article : Google Scholar : PubMed/NCBI | |
Jiang K and Jia J: Smoothened regulation in response to Hedgehog stimulation. Front Biol. 10:475–486. 2015. View Article : Google Scholar | |
Huang P, Zheng S, Wierbowski BM, Kim Y, Nedelcu D, Aravena L, Liu J, Kruse AC and Salic A: Structural basis of smoothened activation in hedgehog signaling. Cell. 174:312–324.e16. 2018. View Article : Google Scholar : PubMed/NCBI | |
Qi Y, Liu H and Lin X: Sumoylation stabilizes smoothened to promote hedgehog signaling. Dev Cell. 39:385–387. 2016. View Article : Google Scholar : PubMed/NCBI | |
Zhang B, Zhuang T, Lin Q, Yang B, Xu X, Xin G, Zhu S, Wang G, Yu B, Zhang T, et al: Patched1-ArhGAP36-PKA-Inversin axis determines the ciliary translocation of Smoothened for Sonic Hedgehog pathway activation. Proc Natl Acad Sci USA. 116:874–879. 2019. View Article : Google Scholar : PubMed/NCBI | |
Rohatgi R and Scott MP: Cell biology. Arrestin' movement in cilia. Science. 320:1726–1727. 2008. View Article : Google Scholar : PubMed/NCBI | |
Cochrane CR, Szczepny A, Watkins DN and Cain JE: Hedgehog signaling in the maintenance of cancer stem cells. Cancers (Basel). 7:1554–1585. 2015. View Article : Google Scholar | |
Carpenter RL and Ray H: Safety and tolerability of sonic hedgehog pathway inhibitors in cancer. Drug Saf. 42:263–279. 2019. View Article : Google Scholar : PubMed/NCBI | |
Hoy SM: Glasdegib: First Global Approval. Drugs. 79:207–213. 2019. View Article : Google Scholar : PubMed/NCBI | |
Pietrobono S, Gagliardi S and Stecca B: Non-canonical hedgehog signaling pathway in cancer: Activation of GLI transcription factors beyond smoothened. Front Genet. 10:5562019. View Article : Google Scholar : PubMed/NCBI | |
Peer E, Tesanovic S and Aberger F: Next-generation hedgehog/GLI pathway inhibitors for cancer therapy. Cancers. 11:5382019. View Article : Google Scholar : | |
Sabol M, Trnski D, Musani V, Ozretić P and Levanat S: Role of GLI Transcription factors in pathogenesis and their potential as new therapeutic targets. Int J Mol Sci. 19:25622018. View Article : Google Scholar : | |
Ruppert JM, Kinzler KW, Wong AJ, Bigner SH, Kao FT, Law ML, Seuanez HN, O'Brien SJ and Vogelstein B: The GLI-Kruppel family of human genes. Mol Cell Biol. 8:3104–3113. 1988. View Article : Google Scholar : PubMed/NCBI | |
Carpenter RL and Lo HW: Hedgehog Pathway and GLI1 Isoforms in Human Cancer. Discov Med. 13:105–113. 2013. | |
Cao X, Geradts J, Dewhirst MW and Lo HW: Upregulation of VEGF-A and CD24 gene expression by the tGLI1 transcription factor contributes to the aggressive behavior of breast cancer cells. Oncogene. 31:104–115. 2012. View Article : Google Scholar | |
Carpenter RL and Lo HW: Identification, Functional Characterization, and Pathobiological Significance of GLI1 Isoforms in Human Cancers. Vitamins, Hormones. 88. Elsevier; pp. 115–140. 2012, View Article : Google Scholar | |
Niewiadomski P, Niedziółka SM, Markiewicz Ł, Uśpieński T, Baran B and Chojnowska K: Gli Proteins: Regulation in development and cancer. Cells. 8:1472019. View Article : Google Scholar : | |
Pal K, Hwang SH, Somatilaka B, Badgandi H, Jackson PK, DeFea K and Mukhopadhyay S: Smoothened determines β-arrestin-mediated removal of the G protein-coupled receptor Gpr161 from the primary cilium. J Cell Biol. 212:861–875. 2016. View Article : Google Scholar : PubMed/NCBI | |
Briscoe J and Thérond PP: The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol. 14:416–429. 2013. View Article : Google Scholar : PubMed/NCBI | |
Montagnani V and Stecca B: Role of protein kinases in hedgehog pathway control and implications for cancer therapy. Cancers. 11:4492019. View Article : Google Scholar : | |
Mirza AN, McKellar SA, Urman NM, Brown AS, Hollmig T, Aasi SZ and Oro AE: LAP2 proteins chaperone GLI1 movement between the lamina and chromatin to regulate transcription. Cell. 176:198–212.e15. 2019. View Article : Google Scholar | |
Canettieri G, Di Marcotullio L, Greco A, Coni S, Antonucci L, Infante P, Pietrosanti L, De Smaele E, Ferretti E, Miele E, et al: Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation. Nat Cell Biol. 12:132–142. 2010. View Article : Google Scholar : PubMed/NCBI | |
Bangs F and Anderson KV: Primary cilia and mammalian hedgehog signaling. Cold Spring Harb Perspect Biol. 9:a0281752017. View Article : Google Scholar | |
Wong SY, Seol AD, So PL, Ermilov AN, Bichakjian CK, Epstein EH Jr, Dlugosz AA and Reiter JF: Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med. 15:1055–1061. 2009. View Article : Google Scholar : PubMed/NCBI | |
Han YG, Kim HJ, Dlugosz AA, Ellison DW and Alvarez-Buylla A: Dual and opposing roles of primary cilia in medulloblastoma development. Nat Med. 15:1062–1065. 2010. View Article : Google Scholar | |
Quaglio D, Infante P, Di Marcotullio L, Botta B and Mori M: Hedgehog signaling pathway inhibitors: An updated patent review (2015-present). Expert Opin Ther Pat. 30:235–250. 2020. View Article : Google Scholar : PubMed/NCBI | |
Perea SE, Baladrón I, Valenzuela C and Perera Y: CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation. Semin Oncol. 45:58–67. 2018. View Article : Google Scholar : PubMed/NCBI | |
Huang S and Houghton PJ: Targeting mTOR signaling for cancer therapy. Curr Opin Pharmacol. 3:371–377. 2003. View Article : Google Scholar : PubMed/NCBI | |
Sullivan RJ, Infante JR, Janku F, Wong DJL, Sosman JA, Keedy V, Patel MR, Shapiro GI, Mier JW, Tolcher AW, et al: First-in-Class ERK1/2 Inhibitor Ulixertinib (BVD-523) in Patients with MAPK mutant advanced solid tumors: Results of a phase i dose-escalation and expansion study. Cancer Discov. 8:184–195. 2018. View Article : Google Scholar | |
Xing Y, Lin NU, Maurer MA, Chen H, Mahvash A, Sahin A, Akcakanat A, Li Y, Abramson V, Litton J, et al: Phase II trial of AKT inhibitor MK-2206 in patients with advanced breast cancer who have tumors with PIK3CA or AKT mutations, and/or PTEN loss/PTEN mutation. Breast Cancer Res. 21:782019. View Article : Google Scholar : PubMed/NCBI | |
Chen H, Shen J, Choy E, Hornicek FJ, Shan A and Duan Z: Targeting DYRK1B suppresses the proliferation and migration of liposarcoma cells. Oncotarget. 9:13154–13166. 2017. View Article : Google Scholar | |
Piirsoo A, Kasak L, Kauts ML, Loog M, Tints K, Uusen P, Neuman T and Piirsoo M: Protein kinase inhibitor SU6668 attenuates positive regulation of Gli proteins in cancer and multipotent progenitor cells. Biochim Biophys Acta. 1843:703–714. 2014. View Article : Google Scholar : PubMed/NCBI | |
Schachter KA and Krauss RS: Murine models of holoprosencephaly. Curr Top Dev Biol. 84:139–170. 2008. View Article : Google Scholar | |
Barratt KS and Arkell RM: ZIC2 in Holoprosencephaly. Zic family: Evolution, Development and Disease. Aruga J: Springer; Singapore: pp. 269–299. 2018, View Article : Google Scholar | |
Chen X, Yang S, Zeng J and Chen M: miR-1271-5p inhibits cell proliferation and induces apoptosis in acute myeloid leukemia by targeting ZIC2. Mol Med Rep. 19:508–514. 2019. | |
Li Q, Shi J and Xu X: MicroRNA-1271-5p inhibits the tumorigenesis of ovarian cancer through targeting E2F5 and negatively regulates the mTOR signaling pathway. Panminerva Med. May 14–2020.Online ahead of print. | |
Li X, Liu H, Lv Y, Yu W, Liu X and Liu C: MiR-130a-5p/Foxa2 axis modulates fetal lung development in congenital diaphragmatic hernia by activating the Shh/Gli1 signaling pathway. Life Sci. 241:1171662020. View Article : Google Scholar | |
Xian X, Tang L, Wu C and Huang L: miR-23b-3p and miR-130a-5p affect cell growth, migration and invasion by targeting CB1R via the Wnt/β-catenin signaling pathway in gastric carcinoma. Onco Targets Ther. 11:7503–7512. 2018. View Article : Google Scholar : | |
Huang JL, Fu YP, Gan W, Liu G, Zhou PY, Zhou C, Sun BY, Guan RY, Zhou J, Fan J, et al: Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis. Cancer Lett. 476:140–151. 2020. View Article : Google Scholar : PubMed/NCBI | |
Yu Y, Yu F and Sun P: MicroRNA-1246 promotes melanoma progression through targeting FOXA2. Onco Targets Ther. 13:1245–1253. 2020. View Article : Google Scholar : PubMed/NCBI | |
Jeong JH, Park SJ, Dickinson SI and Luo JL: A constitutive intrinsic inflammatory signaling circuit composed of miR-196b, Meis2, PPP3CC, and p65 drives prostate cancer castration resistance. Mol Cell. 65:154–167. 2017. View Article : Google Scholar : PubMed/NCBI | |
Guan L, Li T, Ai N, Wang W, He B, Bai Y, Yu Z, Li M, Dong S, Zhu Q, et al: MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma. J Exp Clin Cancer Res. 38:4172019. View Article : Google Scholar | |
Richbourg HA, Hu DP, Xu Y, Barczak AJ and Marcucio RS: miR-199 family contributes to regulation of sonic hedgehog expression during craniofacial development. Dev Dyn. 249:1062–1076. 2020. View Article : Google Scholar : PubMed/NCBI | |
Ozretić P, Trnski D, Musani V, Maurac I, Kalafatić D, Orešković S, Levanat S and Sabol M: Non-canonical Hedgehog signaling activation in ovarian borderline tumors and ovarian carcinomas. Int J Oncol. 51:1869–1877. 2017. View Article : Google Scholar | |
Mishra P, Panda A, Bandyopadhyay A, Kumar H and Mohiddin G: Sonic hedgehog signalling pathway and ameloblastoma-a review. J Clin Diagn Res. 9:ZE10–ZE13. 2015.PubMed/NCBI | |
Bhuria V, Xing J, Scholta T, Bui KC, Nguyen MLT, Malek NP, Bozko P and Plentz RR: Hypoxia induced Sonic Hedgehog signaling regulates cancer stemness, epithelial-to-mesenchymal transition and invasion in cholangiocarcinoma. Exp Cell Res. 385:1116712019. View Article : Google Scholar : PubMed/NCBI | |
Lei J, Fan L, Wei G, Chen X, Duan W, Xu Q, Sheng W, Wang K and Li X: Gli-1 is crucial for hypoxia-induced epithelial- mesenchymal transition and invasion of breast cancer. Tumour Biol. 36:3119–3126. 2015. View Article : Google Scholar | |
Seto M, Ohta M, Asaoka Y, Ikenoue T, Tada M, Miyabayashi K, Mohri D, Tanaka Y, Ijichi H, Tateishi K, et al: Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer. Mol Carcinog. 48:703–712. 2009. View Article : Google Scholar : PubMed/NCBI | |
Stecca B, Mas C, Clement V, Zbinden M, Correa R, Piguet V, Beermann F, Ruiz I and Altaba A: Melanomas require HEDGEHOG-GLI signaling regulated by interactions between GLI1 and the RAS-MEK/AKT pathways. Proc Natl Acad Sci USA. 104:5895–5900. 2007. View Article : Google Scholar : PubMed/NCBI | |
Singh R, Dhanyamraju PK and Lauth M: DYRK1B blocks canonical and promotes non-canonical Hedgehog signaling through activation of the mTOR/AKT pathway. Oncotarget. 8:833–845. 2017. View Article : Google Scholar : | |
Stemmer V, de Craene B, Berx G and Behrens J: Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene. 27:5075–5080. 2008. View Article : Google Scholar : PubMed/NCBI | |
Rishikaysh P, Dev K, Diaz D, Qureshi WMS, Filip S and Mokry J: Signaling involved in hair follicle morphogenesis and development. Int J Mol Sci. 15:1647–1670. 2014. View Article : Google Scholar : PubMed/NCBI | |
Qi Y, Zhao W, Wang Z, Xie Q, Cao J and Meng X: Cross regulation of signaling pathways in gastrointestinal stromal tumor. Oncol Lett. 16:6770–6776. 2018.PubMed/NCBI | |
Yoon JW, Gallant M, Lamm ML, Iannaccone S, Vieux KF, Proytcheva M, Hyjek E, Iannaccone P and Walterhouse D: Noncanonical regulation of the hedgehog mediator GLI1 by c-MYC in burkitt lymphoma. Mol Cancer Res. 11:604–615. 2013. View Article : Google Scholar : PubMed/NCBI | |
Whitson RJ, Lee A, Urman NM, Mirza A, Yao CY, Brown AS, Li JR, Shankar G, Fry MA, Atwood SX, et al: Noncanonical hedgehog pathway activation through SRF-MKL1 promotes drug resistance in basal cell carcinomas. Nat Med. 24:271–281. 2018. View Article : Google Scholar : PubMed/NCBI | |
Liang R, Kagwiria R, Zehender A, Dees C, Bergmann C, Ramming A, Krasowska D, Michalska-Jakubus M, Kreuter A, Kraner ME, et al: Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc. Ann Rheum Dis. 78:1269–1273. 2019. View Article : Google Scholar : PubMed/NCBI | |
Yang H, Hu L, Liu Z, Qin Y, Li R, Zhang G, Zhao B, Bi C, Lei Y and Bai Y: Inhibition of Gli1-mediated prostate cancer cell proliferation by inhibiting the mTOR/S6K1 signaling pathway. Oncol Lett. 14:7970–7976. 2017.PubMed/NCBI | |
Robbins DJ, Fei DL and Riobo NA: The hedgehog signal transduction network. Sci Signal. 5:re62012. View Article : Google Scholar : PubMed/NCBI | |
Barnes EA, Kong M, Ollendorff V and Donoghue D: Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J. 20:2214–2223. 2001. View Article : Google Scholar : PubMed/NCBI | |
Barnes EA, Heidtman KJ and Donoghue DJ: Constitutive activation of the shh-ptc1 pathway by a patched1 mutation identified in BCC. Oncogene. 24:902–915. 2005. View Article : Google Scholar | |
Thibert C: Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog. Science. 301:843–846. 2003. View Article : Google Scholar : PubMed/NCBI | |
Mille F, Thibert C, Fombonne J, Rama N, Guix C, Hayashi H, Corset V, Reed JC and Mehlen P: The Patched dependence receptor triggers apoptosis through a DRAL-caspase-9 complex. Nat Cell Biol. 11:739–746. 2009. View Article : Google Scholar : PubMed/NCBI | |
Sasaki N, Kurisu J and Kengaku M: Sonic hedgehog signaling regulates actin cytoskeleton via Tiam1-Rac1 cascade during spine formation. Mol Cell Neurosci. 45:335–344. 2010. View Article : Google Scholar : PubMed/NCBI | |
Chinchilla P, Xiao L, Kazanietz MG and Riobo NA: Hedgehog proteins activate pro-angiogenic responses in endothelial cells through non-canonical signaling pathways. Cell Cycle. 9:570–579. 2010. View Article : Google Scholar : PubMed/NCBI | |
Polizio AH, Chinchilla P, Chen X, Kim S, Manning DR and Riobo NA: Heterotrimeric G i proteins link hedgehog signaling to activation of rho small GTPases to promote fibroblast migration. J Biol Chem. 286:19589–19596. 2011. View Article : Google Scholar : PubMed/NCBI | |
Belgacem YH and Borodinsky LN: Sonic hedgehog signaling is decoded by calcium spike activity in the developing spinal cord. Proc Natl Acad Sci USA. 108:4482–4487. 2011. View Article : Google Scholar : PubMed/NCBI | |
Gupta S, Takebe N and LoRusso P: Targeting the Hedgehog pathway in cancer. Ther Adv Med Oncol. 2:237–250. 2010. View Article : Google Scholar | |
Reifenberger J, Wolter M, Knobbe CB, Köhler B, Schönicke A, Scharwächter C, Kumar K, Blaschke B, Ruzicka T and Reifenberger G: Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol. 152:43–51. 2005. View Article : Google Scholar : PubMed/NCBI | |
Cheng WT, Xu K, Tian DY, Zhang ZG, Liu LJ and Chen Y: Role of Hedgehog signaling pathway in proliferation and invasiveness of hepatocellular carcinoma cells. Int J Oncol. 34:829–836. 2009.PubMed/NCBI | |
Tian H, Callahan CA, DuPree KJ, Darbonne WC, Ahn CP, Scales SJ and de Sauvage FJ: Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc Natl Acad Sci USA. 106:4254–4259. 2009. View Article : Google Scholar : PubMed/NCBI | |
Yauch RL, Gould SE, Scales SJ, Tang T, Tian H, Ahn CP, Marshall D, Fu L, Januario T, Kallop D, et al: A paracrine requirement for hedgehog signalling in cancer. Nature. 455:406–410. 2008. View Article : Google Scholar : PubMed/NCBI | |
Jeng KS, Chang CF and Lin SS: Sonic hedgehog signaling in organogenesis, tumors, and tumor microenvironments. Int J Mol Sci. 21:7582020. View Article : Google Scholar : | |
Santi A, Kugeratski FG and Zanivan S: Cancer Associated Fibroblasts: The Architects of Stroma Remodeling. Proteomics. 18:e17001672018. View Article : Google Scholar | |
Valenti G, Quinn HM, Heynen GJJE, Lan L, Holland JD, Vogel R, Wulf-Goldenberg A and Birchmeier W: Cancer stem cells regulate cancer-associated fibroblasts via activation of hedgehog signaling in mammary gland tumors. Cancer Res. 77:2134–2147. 2017. View Article : Google Scholar : PubMed/NCBI | |
von Ahrens D, Bhagat TD, Nagrath D, Maitra A and Verma A: The role of stromal cancer-associated fibroblasts in pancreatic cancer. J Hematol Oncol. 10:762017. View Article : Google Scholar : PubMed/NCBI | |
Petty AJ, Li A, Wang X, Dai R, Heyman B, Hsu D, Huang X and Yang Y: Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment. J Clin Invest. 129:5151–5162. 2019. View Article : Google Scholar : PubMed/NCBI | |
Fan Q, He M, Sheng T, Zhang X, Sinha M, Luxon B, Zhao X and Xie J: Requirement of TGFbeta Signaling for SMO-mediated carcinogenesis. J Biol Chem. 285:36570–36576. 2010. View Article : Google Scholar : PubMed/NCBI | |
Maximov V, Chen Z, Wei Y, Robinson MH, Herting CJ, Shanmugam NS, Rudneva VA, Goldsmith KC, MacDonald TJ, Northcott PA, et al: Tumour-associated macrophages exhibit anti-tumoural properties in Sonic Hedgehog medulloblastoma. Nat Commun. 10:24102019. View Article : Google Scholar : PubMed/NCBI | |
Moch H, Cubilla AL, Humphrey PA, Reuter VE and Ulbright TM: The 2016 WHO classification of tumours of the urinary system and male genital organs-part a: Renal, penile, and testicular tumours. Eur Urol. 70:93–105. 2016. View Article : Google Scholar : PubMed/NCBI | |
Cheville JC, Lohse CM, Zincke H, Weaver AL and Blute ML: Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 27:612–624. 2003. View Article : Google Scholar : PubMed/NCBI | |
Sanchez DJ and Simon MC: Genetic and metabolic hallmarks of clear cell renal cell carcinoma. Biochim Biophys Acta Rev Cancer. 1870:23–31. 2018. View Article : Google Scholar : PubMed/NCBI | |
Brugarolas J: Molecular genetics of clear-cell renal cell carcinoma. J Clin Oncol. 32:1968–1976. 2014. View Article : Google Scholar : PubMed/NCBI | |
Gossage L, Eisen T and Maher ER: VHL, the story of a tumour suppressor gene. Nat Rev Cancer. 15:55–64. 2015. View Article : Google Scholar | |
Le Tourneau C, Raymond E and Faivre S: Sunitinib: A novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST). Ther Clin Risk Manag. 3:341–348. 2007. View Article : Google Scholar | |
Dormoy V, Danilin S, Lindner V, Thomas L, Rothhut S, Coquard C, Helwig JJ, Jacqmin D, Lang H and Massfelder T: The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth. Mol Cancer. 8:1232009. View Article : Google Scholar : PubMed/NCBI | |
Samaratunga H, Gianduzzo T and Delahunt B: The ISUP system of staging, grading and classification of renal cell neoplasia. J Kidney Cancer VHL. 1:26–39. 2014. View Article : Google Scholar : PubMed/NCBI | |
Jäger W, Thomas C, Fazli L, Hurtado-Coll A, Li E, Janssen C, Gust KM, So AI, Hainz M, Schmidtmann I, et al: DHH is an independent prognosticator of oncologic outcome of clear cell renal cell carcinoma. J Urol. 192:1842–1848. 2014. View Article : Google Scholar : PubMed/NCBI | |
Furukawa J, Miyake H and Fujisawa M: GLI2 expression levels in radical nephrectomy specimens as a predictor of disease progression in patients with metastatic clear cell renal cell carcinoma following treatment with sunitinib. Mol Clin Oncol. 5:186–192. 2016. View Article : Google Scholar : PubMed/NCBI | |
Behnsawy HM, Shigemura K, Meligy FY, Yamamichi F, Yamashita M, Haung WC, Li X, Miyake H, Tanaka K, Kawabata M, et al: Possible role of sonic hedgehog and epithelial-mesenchymal transition in renal cell cancer progression. Korean J Urol. 54:547–554. 2013. View Article : Google Scholar : PubMed/NCBI | |
Kotulak-Chrzaszcz A, Klacz J, Matuszewski M, Kmiec Z and Wierzbicki P: Expression of the Sonic Hedgehog pathway components in clear cell renal cell carcinoma. Oncol Lett. 18:5801–5810. 2019.PubMed/NCBI | |
Shang Z, Zhao T, Ou T, Yan H, Cui B, Wang Q, Wu J, Jia C, Cui X and Li J: The level of zinc finger of the cerebellum 2 is predictive of overall survival in clear cell renal cell carcinoma. Transl Androl Urol. 9:614–620. 2020. View Article : Google Scholar : PubMed/NCBI | |
Jia Z, Wan F, Zhu Y, Shi G, Zhang H, Dai B and Ye D: Forkhead-box series expression network is associated with outcome of clear-cell renal cell carcinoma. Oncol Lett. 15:8669–8680. 2018.PubMed/NCBI | |
Zhou J, Wu K, Gao D, Zhu G, Wu D, Wang X, Chen Y, Du Y, Song W, Ma Z, et al: Reciprocal regulation of hypoxia-inducible factor 2α and GLI1 expression associated with the radioresistance of renal cell carcinoma. Int J Radiat Oncol Biol Phys. 90:942–951. 2014. View Article : Google Scholar | |
Zhou J, Zhu G, Huang J, Li L, Du Y, Gao Y, Wu D, Wang X, Hsieh JT, He D and Wu K: Non-canonical GLI1/2 activation by PI3K/AKT signaling in renal cell carcinoma: A novel potential therapeutic target. Cancer Lett. 370:313–323. 2016. View Article : Google Scholar | |
D'Amato C, Rosa R, Marciano R, D'Amato V, Formisano L, Nappi L, Raimondo L, Di Mauro C, Servetto A, Fulciniti F, et al: Inhibition of hedgehog signalling by NVP-LDE225 (Erismodegib) interferes with growth and invasion of human renal cell carcinoma cells. Br J Cancer. 111:1168–1179. 2014. View Article : Google Scholar : PubMed/NCBI | |
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI | |
Zhang X and Zhang Y: Bladder cancer and genetic mutations. Cell Biochem Biophys. 73:65–69. 2015. View Article : Google Scholar | |
Mobley D and Baum N: Smoking: Its impact on urologic health. Rev Urol. 17:220–225. 2015. | |
Jalanko T, de Jong JJ, Gibb EA, Seiler R and Black PC: Genomic subtyping in bladder cancer. Curr Urol Rep. 21:92020. View Article : Google Scholar : PubMed/NCBI | |
He HC, Chen JH, Chen XB, Qin GQ, Cai C, Liang YX, Han ZD, Dai QS, Chen YR, Zeng GH, et al: Expression of hedgehog pathway components is associated with bladder cancer progression and clinical outcome. Pathol Oncol Res. 18:349–355. 2012. View Article : Google Scholar | |
Nedjadi T, Salem N, Khayyat D, Al-Sayyad A, Al-Ammari A and Al-Maghrabi J: Sonic hedgehog expression is associated with lymph node invasion in urothelial bladder cancer. Pathol Oncol Res. 25:1067–1073. 2019. View Article : Google Scholar : | |
Xie R, Chen X, Chen Z, Huang M, Dong W, Gu P, Zhang J, Zhou Q, Dong W, Han J, et al: Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM. Cancer Lett. 449:31–44. 2019. View Article : Google Scholar : PubMed/NCBI | |
Islam SS, Mokhtari RB, Noman AS, Uddin M, Rahman MZ, Azadi MA, Zlotta A, van der Kwast T, Yeger H and Farhat WA: Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer. Mol Carcinog. 55:537–551. 2016. View Article : Google Scholar | |
Kitagawa K, Shigemura K, Sung SY, Chen KC, Huang CC, Chiang YT, Liu MC, Huang TW, Yamamichi F, Shirakawa T and Fujisawa M: Possible correlation of sonic hedgehog signaling with epithelial-mesenchymal transition in muscle-invasive bladder cancer progression. J Cancer Res Clin Oncol. 145:2261–2271. 2019. View Article : Google Scholar : PubMed/NCBI | |
Kim S, Kim Y, Kong J, Kim E, Choi JH, Yuk HD, Lee H, Kim HR, Lee KH, Kang M, et al: Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer. Elife. 8:e430242019. View Article : Google Scholar : PubMed/NCBI | |
Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, Gershenwald JE, Compton CC, Hess KR, Sullivan DC, et al: AJCC cancer staging manual. 8th edition. Springer International Publishing; Chicago, IL: 2017, View Article : Google Scholar | |
Ho J, Du Y, Wong OG, Siu MK, Chan KK and Cheung AN: Downregulation of the gli transcription factors regulator Kif7 facilitates cell survival and migration of choriocarcinoma cells. PLoS One. 9:e1082482014. View Article : Google Scholar : PubMed/NCBI | |
Yap J, Fox R, Narsia N, Pinheiro-Maia S, Pounds R, Woodman C, Luesley D, Ganesan R, Kehoe S and Dawson C: Under expression of the Sonic Hedgehog receptor, Patched1 (PTCH1), is associated with an increased risk of local recurrence in squamous cell carcinoma of the vulva arising on a background of Lichen Sclerosus. PLoS One. 13:e02065532018. View Article : Google Scholar : PubMed/NCBI | |
Rosen DG, Yang G, Liu G, Mercado-Uribe I, Chang B, Xiao XS, Zheng J, Xue FX and Liu J: Ovarian cancer: Pathology, biology, and disease models. Front Biosci (Landmark Ed). 14:2089–2102. 2009. View Article : Google Scholar | |
Levanat S, Musani V, Komar A and Orešković S: Role of the Hedgehog/Patched Signaling Pathway in Oncogenesis: A new polymorphism in the PTCH gene in ovarian fibroma. Ann N Y Acad Sci. 1030:134–143. 2004. View Article : Google Scholar | |
Marchini S, Poynor E, Barakat RR, Clivio L, Cinquini M, Fruscio R, Porcu L, Bussani C, D'Incalci M, Erba E, et al: The zinc finger gene ZIC2 has features of an oncogene and its overexpression correlates strongly with the clinical course of epithelial ovarian cancer. Clin Cancer Res. 18:4313–4324. 2012. View Article : Google Scholar : PubMed/NCBI | |
Salem M, O'Brien JA, Bernaudo S, Shawer H, Ye G, Brkić J, Amleh A, Vanderhyden BC, Refky B, Yang BB, et al: miR-590-3p Promotes ovarian cancer growth and metastasis via a Novel FOXA2-versican pathway. Cancer Res. 78:4175–4190. 2018. View Article : Google Scholar : PubMed/NCBI | |
Peng Q, Qin J, Zhang Y, Cheng X, Wang X, Lu W, Xie X and Zhang S: Autophagy maintains the stemness of ovarian cancer stem cells by FOXA2. J Exp Clin Cancer Res. 36:1712017. View Article : Google Scholar : PubMed/NCBI | |
Musani V, Sabol M, Car D, Ozretić P, Kalafatić D, Maurac I, Orešković S and Levanat S: PTCH1 gene polymorphisms in ovarian tumors: Potential protective role of c.3944T allele. Gene. 517:55–59. 2013. View Article : Google Scholar : PubMed/NCBI | |
Cretnik M, Musani V, Oreskovic S, Leovic D and Levanat S: The Patched gene is epigenetically regulated in ovarian dermoids and fibromas, but not in basocellular carcinomas. Int J Mol Med. 19:875–883. 2007.PubMed/NCBI | |
Hainsworth JD, Meric-Bernstam F, Swanton C, Hurwitz H, Spigel DR, Sweeney C, Burris H, Bose R, Yoo B, Stein A, et al: Targeted therapy for advanced solid tumors on the basis of molecular profiles: Results from mypathway, an open-label, phase IIa multiple basket study. J Clin Oncol. 36:536–542. 2018. View Article : Google Scholar : PubMed/NCBI | |
Liao X, Siu MK, Au CW, Wong ES, Chan HY, Ip PP, Ngan HY and Cheung AN: Aberrant activation of hedgehog signaling pathway in ovarian cancers: Effect on prognosis, cell invasion and differentiation. Carcinogenesis. 30:131–140. 2009. View Article : Google Scholar | |
Yang L, He J, Huang S, Zhang X, Bian Y, He N, Zhang H and Xie J: Activation of hedgehog signaling is not a frequent event in ovarian cancers. Mol Cancer. 8:1122009. View Article : Google Scholar : PubMed/NCBI | |
Schmid S, Bieber M, Zhang F, Zhang M, He B, Jablons D and Teng NN: Wnt and hedgehog gene pathway expression in serous ovarian cancer. Int J Gynecol Cancer. 21:975–980. 2011. View Article : Google Scholar : PubMed/NCBI | |
Trnski D, Gregorić M, Levanat S, Ozretić P, Rinčić N, Vidaković TM, Kalafatić D, Maurac I, Orešković S, Sabol M and Musani V: Regulation of survivin isoform expression by GLI proteins in ovarian cancer. Cells. 8:1282019. View Article : Google Scholar : | |
Vlčková K, Ondrušová L, Vachtenheim J, Réda J, Dundr P, Zadinová M, Žáková P and Poučková P: Survivin, a novel target of the Hedgehog/GLI signaling pathway in human tumor cells. Cell Death Dis. 7:e20482016. View Article : Google Scholar | |
Zhang H, Wang Y, Chen T, Zhang Y, Xu R, Wang W, Cheng M and Chen Q: Aberrant activation of hedgehog signalling promotes cell migration and invasion via matrix metalloproteinase-7 in ovarian cancer cells. J Cancer. 10:990–1003. 2019. View Article : Google Scholar : PubMed/NCBI | |
Xu M, Hu X, Zhang M and Ge Y: What is the impact of BIRC5 gene polymorphisms on urinary cancer susceptibility? Evidence from 9348 subjects. Gene. 733:1442682020. View Article : Google Scholar | |
Sneha S, Nagare RP, Sidhanth C, Krishnapriya S, Garg M, Ramachandran B, Murhekar K, Sundersingh S and Ganesan TS: The hedgehog pathway regulates cancer stem cells in serous adenocarcinoma of the ovary. Cell Oncol (Dordr). 43:601–616. 2020. View Article : Google Scholar | |
Sun X, Song J, Li E, Geng H, Li Y, Yu D and Zhong C: (-)-Epigallocatechin-3-gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway. Oncol Rep. 42:425–435. 2019.PubMed/NCBI | |
Li X, Wang X, Xie C, Zhu J, Meng Y, Chen Y, Li Y, Jiang Y, Yang X, Wang S, et al: Sonic hedgehog and Wnt/β-catenin pathways mediate curcumin inhibition of breast cancer stem cells. Anticancer Drugs. 29:208–215. 2018. View Article : Google Scholar : PubMed/NCBI | |
Rojo-León V, García C, Valencia C, Méndez MA, Wood C and Covarrubias L: The E6/E7 oncogenes of human papilloma virus and estradiol regulate hedgehog signaling activity in a murine model of cervical cancer. Exp Cell Res. 381:311–322. 2019. View Article : Google Scholar : PubMed/NCBI | |
Chen H, Wang J, Yang H, Chen D and Li P: Association between FOXM1 and hedgehog signaling pathway in human cervical carcinoma by tissue microarray analysis. Oncol Lett. 12:2664–2673. 2016. View Article : Google Scholar : PubMed/NCBI | |
Vishnoi K, Mahata S, Tyagi A, Pandey A, Verma G, Jadli M, Singh T, Singh SM and Bharti AC: Cross-talk between human papillomavirus oncoproteins and hedgehog signaling synergistically promotes stemness in cervical cancer cells. Sci Rep. 6:343772016. View Article : Google Scholar : PubMed/NCBI | |
Wang XH, He X, Jin HY, Liang JX and Li N: Effect of hypoxia on the Twist1 in EMT of cervical cancer cells. Eur Rev Med Pharmacol Sci. 22:6633–6639. 2018.PubMed/NCBI | |
Wang YF, Yang HY, Shi XQ and Wang Y: Upregulation of microRNA-129-5p inhibits cell invasion, migration and tumor angiogenesis by inhibiting ZIC2 via downregulation of the Hedgehog signaling pathway in cervical cancer. Cancer Biol Ther. 19:1162–1173. 2018. View Article : Google Scholar : PubMed/NCBI | |
Pereira J, Johnson WE, O'Brien SJ, Jarvis ED, Zhang G, Gilbert MT, Vasconcelos V and Antunes A: Evolutionary Genomics and Adaptive Evolution of the Hedgehog Gene Family (Shh, Ihh and Dhh) in Vertebrates. PLoS One. 9:e741322014. View Article : Google Scholar : PubMed/NCBI | |
Joodi M, Amerizadeh F, Hassanian SM, Erfani M, Ghayour-Mobarhan M, Ferns GA, Khazaei M and Avan A: The genetic factors contributing to hypospadias and their clinical utility in its diagnosis. J Cell Physiol. 234:5519–5523. 2019. View Article : Google Scholar | |
Aurilio G, Cimadamore A, Santoni M, Nolè F, Scarpelli M, Massari F, Lopez-Beltran A, Cheng L and Montironi R: New frontiers in prostate cancer treatment: Are we ready for drug combinations with novel agents? Cells. 9:15222020. View Article : Google Scholar : | |
Le V, He Y, Aldahl J, Hooker E, Yu EJ, Olson A, Kim WK, Lee DH, Wong M, Sheng R, et al: Loss of androgen signaling in mesenchymal sonic hedgehog responsive cells diminishes prostate development, growth, and regeneration. PLoS Genet. 16:e10085882020. View Article : Google Scholar : PubMed/NCBI | |
Datta S and Datta MW: Sonic Hedgehog signaling in advanced prostate cancer. Cell Mol Life Sci. 63:435–448. 2006. View Article : Google Scholar : PubMed/NCBI | |
Yamamichi F, Shigemura K, Behnsawy HM, Meligy FY, Huang WC, Li X, Yamanaka K, Hanioka K, Miyake H, Tanaka K, et al: Sonic hedgehog and androgen signaling in tumor and stromal compartments drives epithelial-mesenchymal transition in prostate cancer. Scand J Urol. 48:523–532. 2014. View Article : Google Scholar : PubMed/NCBI | |
Zhang X, Zhang Y, Lin F, Shi X, Xiang L and Li L: Shh overexpression is correlated with GRP78 and AR expression in primary prostate cancer: Clinicopathological features and outcomes in a chinese cohort. Cancer Manag Res. 12:1569–1578. 2020. View Article : Google Scholar : PubMed/NCBI | |
Tzelepi V, Karlou M, Wen S, Hoang A, Logothetis C, Troncoso P and Efstathiou E: Expression of hedgehog pathway components in prostate carcinoma microenvironment: Shifting the balance towards autocrine signalling: Hedgehog pathway in prostate cancer. Histopathology. 58:1037–1047. 2011. View Article : Google Scholar : PubMed/NCBI | |
U.S. Natinal Library of Medicine: A Pre-surgical Study of LDE225 in Men With High-risk Localized Prostate Cancer (LDE225). ClinicalTrials.gov Identifier: NCT02111187. https://clinicaltrials.gov/ct2/show/NCT02111187. Last updated March 7, 2019. | |
U.S. Natinal Library of Medicine: A Study of Vismodegib in Men With Metastatic CRPC With Accessible Metastatic Lesions for Tumor Biopsy. ClinicalTrials.gov Identifier: NCT02115828. https://clinicaltrials.gov/ct2/show/results/NCT02115828. Last updated July 20, 2018. | |
Antonarakis ES, Heath EI, Smith DC, Rathkopf D, Blackford AL, Danila DC, King S, Frost A, Ajiboye AS, Zhao M, et al: Repurposing itraconazole as a treatment for advanced prostate cancer: A noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer. Oncologist. 18:163–173. 2013. View Article : Google Scholar : PubMed/NCBI | |
Xie H, Paradise BD, Ma WW and Fernandez-Zapico ME: Recent advances in the clinical targeting of hedgehog/GLI signaling in cancer. Cells. 8:3942019. View Article : Google Scholar : | |
Kim JE, Singh RR, Cho-Vega JH, Drakos E, Davuluri Y, Khokhar FA, Fayad L, Medeiros LJ and Vega F: Sonic hedgehog signaling proteins and ATP-binding cassette G2 are aberrantly expressed in diffuse large B-cell lymphoma. Mod Pathol. 22:1312–1320. 2009. View Article : Google Scholar : PubMed/NCBI | |
Ciccone V, Morbidelli L, Ziche M and Donnini S: How to conjugate the stemness marker ALDH1A1 with tumor angiogenesis, progression, and drug resistance. Cancer Drug Resist. 3:26–37. 2020. | |
Bigelow RLH, Chari NS, Unden AB, Spurgers KB, Lee S, Roop DR, Toftgard R and McDonnell TJ: Transcriptional regulation of bcl-2 mediated by the sonic hedgehog signaling pathway through gli-1. J Biol Chem. 279:1197–1205. 2004. View Article : Google Scholar | |
Li J, Xu J, Cui Y, Wang L, Wang B, Wang Q, Zhang X, Qiu M and Zhang Z: Mesenchymal sufu regulates development of mandibular molars via shh signaling. J Dent Res. 98:1348–1356. 2019. View Article : Google Scholar : PubMed/NCBI | |
Wang D, Nagle PW, Wang HH, Smit JK, Faber H, Baanstra M, Karrenbeld A, Chiu RK, Plukker JTM and Coppes RP: Hedgehog pathway as a potential intervention target in esophageal cancer. Cancers (Basel). 11:8212019. View Article : Google Scholar | |
Cai H, Li H, Li J, Li X, Li Y, Shi Y and Wang D: Sonic hedgehog signaling pathway mediates development of hepatocellular carcinoma. Tumour Biol. Oct 15–2016.Epub ahead of print. View Article : Google Scholar | |
Park AK, Lee JY, Cheong H, Ramaswamy V, Park SH, Kool M, Phi JH, Choi SA, Cavalli F, Taylor MD and Kim SK: Subgroup-specific prognostic signaling and metabolic pathways in pediatric medulloblastoma. BMC Cancer. 19:5712019. View Article : Google Scholar : PubMed/NCBI | |
Polychronidou G, Kotoula V, Manousou K, Kostopoulos I, Karayannopoulou G, Vrettou E, Bobos M, Raptou G, Efstratiou I, Dionysopoulos D, et al: Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer. PLoS One. 13:e02082212018. View Article : Google Scholar : PubMed/NCBI | |
Katoh Y and Katoh M: Hedgehog target genes: Mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med. 9:873–886. 2009. View Article : Google Scholar : PubMed/NCBI | |
Jin W, Peng J and Jiang S: The epigenetic regulation of embryonic myogenesis and adult muscle regeneration by histone methylation modification. Biochem Biophys Rep. 6:209–219. 2016.PubMed/NCBI | |
Nasrallah I and Golden JA: Brain, eye, and face defects as a result of ectopic localization of Sonic hedgehog protein in the developing rostral neural tube. Teratology. 64:107–113. 2001. View Article : Google Scholar : PubMed/NCBI | |
Castillo-Azofeifa D, Seidel K, Gross L, Golden EJ, Jacquez B, Klein OD and Barlow LA: SOX2 regulation by hedgehog signaling controls adult lingual epithelium homeostasis. Development. 145:dev1648892018. View Article : Google Scholar : PubMed/NCBI | |
Henno P, Grassin-Delyle S, Belle E, Brollo M, Naline E, Sage E, Devillier P and Israël-Biet D: In smokers, Sonic hedgehog modulates pulmonary endothelial function through vascular endothelial growth factor. Respir Res. 18:1022017. View Article : Google Scholar : PubMed/NCBI |